Resumen. STUDY OBJECTIVES: Study A: to determine the absolute bioavailability of a single 300-mg abacavir hemisulfate tablet. Study B: to determine the. (FDA) ha aprobado Triumeq® comprimidos (600 mg de abacavir, 50 mg de. Bioequivalence of a Dolutegravir, Abacavir and Lamivudine. Therapeutic Category | ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|